News Focus
News Focus
Followers 47
Posts 6231
Boards Moderated 0
Alias Born 11/15/2013

Re: backtoreality post# 392443

Saturday, 08/20/2022 9:50:22 AM

Saturday, August 20, 2022 9:50:22 AM

Post# of 405226
Or that Redesiver failed it's first trial but with more testing went on to be the standard of care. Through the NIH Brilacidin is also getting further testing. Likely even much further.

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y